Latest AKRO reports update at 2024-02-29: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Akero Therapeutics
  4. Financial Statements
  5. Cash Flow
Akero Therapeutics logo
Akero Therapeutics AKRO
$ 20.8 -1.05%
mail-toReport an Error

Akero Therapeutics Cash Flow 2011-2024 | AKRO

Annual Cash Flow Akero Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

 -145 M -92.5 M -79.7 M -70.8 M -35.6 M -4.62 M - - - - - - -

Depreciation & Amortization

 29 K 43 K 41 K 17 K - - - - - - - - -

Accounts Payables

 7.04 M 7.97 M 6.71 M 3.43 M 947 K - - - - - - - -

Accounts Receivables

 - - - - - - - - - - - - -

Total Inventories

 - - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Akero Therapeutics

2023-Q3 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

 - -24.6 M - -67 M - -22.9 M - -53 M - -18.3 M - -47.4 M -33.9 M -11.3 M - -24 M -10.8 M -5.44 M - -2.55 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

 - 11 K - 33 K - 11 K - 30 K - 11 K - 6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

 11.5 M 7.08 M 7.97 M 6.01 M - 4.45 M 6.71 M 6.78 M 2.31 M 4.6 M 3.43 M 3.43 M 3.43 M 3.43 M 947 K 947 K 947 K 947 K 1.37 M 1.37 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency